Abstract:Though obesity-related asthma associated with worse asthma outcomes, optimal treatment approaches for this complex phenotype are still largely unavailable. This state-of-the-art review article synthesizes evidence for existing and emerging treatment approaches for obesity-related asthma and highlights pathways that offer potential targets for novel therapeutics. Existing treatments targeting insulin resistance and obesity, including metformin and glucagon-like-peptide 1 (GLP-1) receptor agonists, have been associated with improved asthma outcomes, though GLP-1R agonist data in asthma is limited to individuals with co-morbid obesity. Monoclonal antibodies approved for treatment of moderate to severe asthma generally appear to be effective in individuals with obesity, though this is based on retrospective or secondary analysis of clinical trials; moreover, while most of these asthma biologics are approved for use in the pediatric population, the impact of obesity on their efficacy has not been well studied in youth. Potential therapeutic targets being investigated include IL-6, arginine metabolites, nitro-fatty acids, and mitochondrial antioxidants, with clinical trials for each currently underway. Potential therapeutic targets include adipose tissue eosinophils and the GLP-1-Arginine-Advanced glycation end products axis, though data in humans is still needed. Finally, transcriptomic and epigenetic studies of "obese asthma" demonstrate enrichment of interferon-related signaling pathways, Rho-GTPase pathways, and integrins, suggesting that these too could represent future treatment targets. We advocate for further study of these potential therapeutic mechanisms and continued investigation of the distinct inflammatory pathways characteristic of obesity-related asthma, in order to facilitate effective treatment development for this unique asthma phenotype.

Obesity and Hormonal Influences on Asthma: Mechanisms, Management Challenges, and Emerging Therapeutic Strategies

Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches.

Obesity alters inflammatory response in the pathology of asthma (Review)

Obesity-related asthma: new insights leading to a different approach

Obesity, Inflammation, and Severe Asthma: an Update

Body Weight and Allergic Asthma: A Narrative Review

Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity

Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation

Association of Obesity and Severe Asthma in Adults

A clinician's guide to effects of obesity on childhood asthma and into adulthood

Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes

Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications

Weight Loss Interventions for Adults With Obesity-Related Asthma

Targeting Lipid Metabolism in Obese Asthma: Perspectives and Therapeutic Opportunities

Asthma, obesity and targeted interventions: an update

The Management of Extrapulmonary Comorbidities and Treatable Traits; Obesity, Physical Inactivity, Anxiety, and Depression, in Adults With Asthma

Optimizing lifestyle interventions in adult patients with comorbid asthma and obesity

Obesity-related asthma and its relationship with microbiota

The Role of Nutritional Factors in Asthma: Challenges and Opportunities for Epidemiological Research

The Role of Peptides in Asthma–Obesity Phenotype

PATHOGENETIC ASPECTS OF THE PHENOTYPE OF BRONCHIAL ASTHMA ASSOCIATED WITH OBESITY